Clover Health Stock

cloverhealth.comFinTech / InsuranceFounded: 2014Funding to Date: $676.33MM

Clover Health is a health insurance company driving to improve the overall state of healthcare in America by integrating the company's systems with doctors, clinicians, and nurse practitioners to help healthcare professionals in the field intervene directly into patients’ wellness to help them avoid acute health episodes.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Clover Health before its SPAC, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Clover Health Stock Price

Forge Price 1
Price no longer available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Clover Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
05/10/2017 Series D $130MM $xx.xx $1.23B Baillie Gifford, Expanding Capital, First Round Capital, Greenoaks Capital, Gv, Palm Drive Capital, Sequoia Capital, Toba Capital, Western Technology Investment
Price per Share
$xx.xx
Shares Outstanding
13,862,526
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Expanding Capital, First Round Capital, Greenoaks Capital, Gv, Palm Drive Capital, Sequoia Capital, Toba Capital, Western Technology Investment
05/23/2016 Series C $160.17MM $xx.xx $835MM Ame Cloud Ventures, Arena Ventures, Casdin Capital, First Round Capital, Floodgate Fund, Greenoaks Capital, Nexus Venture Partners, Refactor Capital, Sequoia Capital, Social Capital, Spark Capital, Wildcat Venture Partners
Price per Share
$xx.xx
Shares Outstanding
19,066,809
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ame Cloud Ventures, Arena Ventures, Casdin Capital, First Round Capital, Floodgate Fund, Greenoaks Capital, Nexus Venture Partners, Refactor Capital, Sequoia Capital, Social Capital, Spark Capital, Wildcat Venture Partners
01/05/2016 Series A-1 $7.5MM $xx.xx $78MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
7,199,261
Liquidation Pref Order
2
Liquidation Pref As Multiplier
3.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
01/05/2016 Series A $5.5MM $xx.xx $70.5MM Athyrium Capital Mgmt, First Round Capital, Nathaniel Turner, Oxeon Partners
Price per Share
$xx.xx
Shares Outstanding
5,274,468
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athyrium Capital Mgmt, First Round Capital, Nathaniel Turner, Oxeon Partners
12/16/2015 Series B $35MM $xx.xx $263MM Athyrium Capital Mgmt, First Round Capital, Sequoia Capital, Social Capital, Wildcat Venture Partners
Price per Share
$xx.xx
Shares Outstanding
10,338,818
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athyrium Capital Mgmt, First Round Capital, Sequoia Capital, Social Capital, Wildcat Venture Partners

Leadership & Board

Leadership

Andrew Toy
President and Chief Technology Officer
Wendy Richey
Chief Compliance Officer
Calvin Chock
Chief Product Officer
Rachel Fish
Chief People Officer
Gary Dees
Chief Information Officer
Sophia Chang
Chief Clinical Informatics Officer
Vivek Garipalli
Co-Founder, Chief Executive Officer and Board Member
Marcel van der Brug
Founder & Chief Scientific Officer
Mark Spektor
Chief Medical Officer
Joseph Wagner
Chief Financial Officer
Kumar Dharmarajan
Chief Scientific Officer

Board

Benny Peretz
Greenoaks Capital
Nathaniel Turner
Andrew Toy
Clover Health
Michael Dixon
Sequoia Capital
Vivek Garipalli
Clover Health
Kris Gale
Clover Health
Phineas Barnes
First Round Capital

Clover Health stock FAQs

plusminus

Can you buy Clover Health stock?

You can no longer buy Clover Health stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

How to buy Clover Health stock?

You can no longer buy Clover Health stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Clover Health stock?

You can no longer sell stock of Clover Health on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

How to sell Clover Health stock?

You can no longer sell stock of Clover Health on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

Is Clover Health a public company?

Clover Health is now a public company traded on NASDAQ with ticker CLOV.
plusminus

What is Clover Health’s stock price?

The stock price of Clover Health is $0.9783 as of 1/18/24.
plusminus

What is Clover Health’s stock ticker symbol?

The ticker symbol of Clover Health is CLOV.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Clover Health’s News and Media Highlights

NASHVILLE, Tenn., July 09, 2021 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq: CLOV) (“Clover”), an innovative technology company committed to...
Clover Health Inc. co-founder and Chief Executive Vivek Garipalli announced the deal in a blog post without disclosing how much was raised, but a person familiar with the matter said the Greenoaks Capital-led Series E round totaled $500 million.
We used sound to tell the story of racial and gender disparities in the San Francisco Bay Area’s tech sector.
Venrock unveils a survey of more than 300 health experts. Here's what they had to say.
Updated on: Nov 22, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.